UCB
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases.
RELATED ARTICLES
Researcher Profile: Eddy Han-Burgess
Eddy Han-Burgess and his team are using a mix of mathematical modeling, big data and artificial inte…
READ MORE
Researcher Profile: Henrik Klitgaard
With nearly 30 years of experience in biopharmaceutical research, Dr. Henrik Klitgaard has dedicated…
READ MORE
Taking Control of Epilepsy
As the most common serious neurological condition in the U.S., epilepsy affects roughly 3.4 million…
READ MORE
Pursuing Novel and Targeted Treatments for Epilepsy
Epilepsy is a complex condition, and it will take an equally complex approach to put an end to the d…
READ MORE
Researcher Profile: Luiz Miguel Camargo
As director of innovation networks at UCB, Dr. Luiz Miguel Camargo helps identify tools that researc…
READ MORE
Researcher Profile: Victor Sloan
As vice president and development strategy lead at UCB, Victor Sloan has worked in the field of rheu…
READ MORE
Tackling Epilepsy to Deliver Value to Patients
Brain diseases affect one in six people around the world. The range of conditions affecting the cent…
READ MOREPOPULAR ARTICLES
HIV/AIDS: From An Acute Fatal Disease to A Chronic, Manageable Condition
The evolution of HIV/AIDS treatment is nothing short of remarkable. In the 1980s, HIV/AIDS was an acute fatal disease. Today it is a chronic, manageable condition thanks to the commitment of biopharmaceutical researchers, health care workers and advocates.
READ MORE
Combatting Sickle Cell Disease with Cell & Gene Therapy
America's biopharmaceutical companies are researching and developing new treatments to alleviate the tremendous burden of this devastating and painful disease and to improve the quality of life for sickle cell patients.
READ MORE
Why Has Research into Alzheimer's Disease Been So Hard?
Why, when we have seen such progress in our ability to treat other diseases, such as cancer, diabetes and HIV, has progress in Alzheimer's research been so difficult to achieve?
READ MORE
5 Recent Developments Advancing Vaccines
As communities continue to grapple with the impact of COVID-19, vaccines have once again come to the forefront as a critical health care tool.
READ MORE
The Innovation Ecosystem Fuels Breakthroughs
Biopharmaceutical research companies are uniquely positioned to take the necessary risks to further advance research into safe and effective treatments for patients.
READ MORE
Blood Cancer Awareness Month: The Promise of Immunotherapy
September is Blood Cancer Awareness Month, which aims to raise awareness for patients with one of several types of blood cancer, including leukemia, lymphoma and myeloma.
READ MORE
Protecting Alzheimer's Research
15 million people will live with Alzheimer's by 2060. We're working to change that.
READ MORE